High Dose Risankizumab for Psoriasis
Clinical trial NCT05283135 · COMPLETED
Trial details
- NCT number
- NCT05283135
- Sponsor
- Oregon Medical Research Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-08-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.